Telix Pharmaceuticals (TLPPF) Shares Outstanding (Diluted) (2023 - 2026)
Powered by 
Analysis
Telix Pharmaceuticals (TLPPF) Shares Outstanding (Diluted) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.52 Bn | 198.53 Bn | 7.24 Bn | 544.00 Mn |
| 2 | Gilead Sciences | 182.98 Bn | 179.80 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 133.52 Bn | 125.67 Bn | 2.84 Bn | 255.20 Mn |
| 4 | Regeneron Pharmaceuticals | 83.12 Bn | 75.12 Bn | 3.93 Bn | 106.00 Mn |
| 5 | Argenx Se | 61.44 Bn | 56.25 Bn | 1.37 Bn | 66.03 Mn |
| 6 | Moderna | 55.46 Bn | 50.32 Bn | 52.00 Mn | 398.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.77 Bn | 31.47 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Biogen | 31.26 Bn | 29.97 Bn | 1.96 Bn | 148.70 Mn |
| 9 | Roivant Sciences | 29.97 Bn | 29.97 Bn | 1.16 Mn | 720.78 Mn |
| 10 | Telix Pharmaceuticals | 3.72 Bn | 3.43 Bn | - | 337.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 337.88 Mn |
| Dec 31, 2025 | 337.88 Mn |
| Dec 31, 2024 | 345.19 Mn |
| Dec 31, 2023 | 323.71 Mn |